Wall Street Zen upgraded shares of Nukkleus (NASDAQ:DFNS – Free Report) from a strong sell rating to a sell rating in a research report sent to investors on Sunday morning.
DFNS has been the topic of a number of other reports. Weiss Ratings downgraded shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. Noble Financial raised shares of Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.
Get Our Latest Analysis on Nukkleus
Nukkleus Price Performance
Institutional Investors Weigh In On Nukkleus
A number of institutional investors have recently made changes to their positions in the company. Millennium Management LLC bought a new stake in shares of Nukkleus in the 4th quarter valued at approximately $60,000. Engineers Gate Manager LP bought a new position in Nukkleus during the fourth quarter worth $96,000. Price T Rowe Associates Inc. MD bought a new position in Nukkleus during the fourth quarter worth $57,000. GM Advisory Group LLC acquired a new position in Nukkleus in the fourth quarter worth $56,000. Finally, State Street Corp boosted its holdings in Nukkleus by 70.7% in the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the period. 12.47% of the stock is currently owned by institutional investors.
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
Read More
- Five stocks we like better than Nukkleus
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
